In this study, we showed that the expression of TRIM67 was associated with a range of clinicopathological features, such as tumor size, differentiation, lymph node metastasis, p-TNM staging, and prognosis. This evidence concerns the gene TRIM67 and metastatic malignant neoplasm in the lymph nodes.